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Introduction
Thanks to advances in modern medicine and better care 
delivered by health care services, persons with chronic 
and debilitating illnesses are living longer. Through-
out Europe and the U.S., these factors are increasingly 
relevant in health care demographics. According to the 
WHO’s annual World Health Statistic Report 2010 [1], 
Japan, Italy and Germany have the highest proportion 
(29%, 26% and 26%) of persons over 60 years of age in 
their populations, ranking slightly higher than Sweden, 
Bulgaria and Greece (all 24%) and far ahead of the U.S., 
China and India (18%, 12%, 7%, respectively).
In comparison with young persons, old persons more of-
ten suffer from disability or impairment, partial or com-
plete, rendering them more prone to developing pressure 
ulcers, also called pressure sores or decubitus [2]. A gen-
eral upward trend in the spread of pressure ulcers has 
been noted in developed countries [3] where its preva-
lence and incidence continue to rise [4]. The proportions 
of this global problem require the appropriate use of 
available means and methods.
The term ‘pressure ulcer’ refers to a tissue lesion that 
may evolve into necrosis, involving the skin and subcu-
taneous tissues, and in severe cases the muscle and bone. 
Pressure ulcers arise from pressure on skin areas overly-
ing a bony prominence or from shear and friction forces 
that cause a circulatory defect [5, 6].
Pressure ulcers are often related to poor prevention or 
care and they significantly diminish the quality of life 
of persons affected [7, 8], prolong the need for care and, 
when hospitalized, prolong their duration of stay [9], in-
curring additional costs to the health care systems. Al-
though based on expert opinion, these, lack actual basis 
in terms of data [10].
Theory/conceptual framework
A literature review based on medical databases was per-
formed to retrieve articles on health economics which 
reported estimates of resource costs for the prevention or 
care of pressure ulcers. Main databanks (PubMed, BMJ, 
Joanna Brings, Cochrane Library, JAMA, Age & Aging, 
MedScape) were consulted to perform the review using 
the following keywords: pressure ulcer or cost-effective-
ness or HTA or advanced dressing or simple dressing.
Sixteen articles were identified as being of interest and 
coherent with the topic of the study for further in depth 
analysis; five articles concerning budget impact or cost-
effectiveness analysis of ulcer prevention [10-14]; three 
articles on the benchmarking concerning costs of dif-
ferent advanced dressing typologies [15-17], one arti-
cle reporting on a cost of illness study [18], one article 
suggesting clinical and economic modelling in order to 
develop guideline for pressure ulcers [19] and two ar-
ticles with a focus on clinical aspects [20, 21]. In addi-
tion, four articles [22-25] were identified for analysis of 
the economic evaluation, patient sample, and treatment 
administered.
Advanced wound dressings were found to be more ef-
fective than simple ones. Moreover, the economic im-
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Summary
Introduction. Pressure ulcer management represents a growing 
problem for medical and social health care systems all over the 
world, particularly in European Union countries where the inci-
dence of pressure ulcers in older persons (> 60 years of age) is 
predicted to rise.
Objectives. The aim of this study was to provide evidence for the 
lower impact on economic resources of using advanced dressings 
for the treatment of pressure ulcers with respect to conventional 
simple dressings.
Methods. Two different models of analysis, derived from Activity 
Based Costing and Health Technology Assessment, were used to 
measure, over a 30-day period, the direct costs incurred by pres-
sure ulcer treatment for community-residing patients receiving 
integrated home care.
Results. Although the mean cost per home care visit was higher in 
the advanced dressings patient group than in the simple dressings 
patient one (€ 22.31 versus € 16.03), analysis of the data revealed 
that the cost of using advanced dressings was lower due to fewer 
home care visits (22 versus 11).
Conclusion. The results underline the fact that decision-makers need 
to improve their understanding of the advantages of taking a long-term 
view with regards to the purchase and use of materials. This could pro-
duce considerable savings of resources in addition to improving treat-
ment efficacy for the benefit of patients and the health care system.
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pact of treatment showed the advanced dressings to have 
a better cost-effectiveness value. In an earlier study [23], 
it was shown that advanced dressings are more cost-ef-
fective than conventional ones, and American national 
nursing wage data [22], showed a mean total cost of US 
$15.90 for advanced dressings versus US $25.31 for 
simple ones, per day.
Methods
Within the above mentioned context, in this multi-centric 
perspective observational health economics study, the 
two cognitive needs identified are related to the lack of 
empiric application within the field of integrated home 
care, taking into account the perspective of the public 
home care provider (region) and the necessity to con-
duct an analysis using a multidimensional methodology. 
Due to these needs, for the research (conducted jointly 
by the Centre for Research on Health Economics, Social 
and Health Care Management – CREMS of Carlo Cat-
taneo –LIUC University, and the Italian National Insti-
tute of Health - ISS) a cost-effectiveness approach was 
taken. The principal objective of the study was to de-
termine whether there is an economic or organizational 
advantage for the provider [26] and to assess the equity 
impact, from the patient’s point of view, of the use of 
advanced dressings rather than simple ones in the treat-
ment of pressure ulcers in community-residing patients 
receiving integrated home care. This was to be done, us-
ing two different models of analysis derived from Activ-
ity Based Costing approach, considering only direct cost 
absorption and applying Health Technology Assessment 
methodology. In all, 23 health care centers in Italy ac-
cepted the invitation to participate in this study.
The output was the mean daily and monthly costs de-
rived from three components of direct costs: gross cost 
(VAT inclusive) taken from provider supplier records of 
medications and devices, personnel costs, and transport 
costs. Personnel costs were calculated depending on the 
type of professional health care worker who visited the 
patient. Transport costs were measured in distance from 
the health care center to the patient’s home, type of mo-
tor vehicle, and related fuel consumption. Economic da-
ta were collected in 2008 and discounted at 2010 value 
considering Italian inflation rates [27].
The analysis of the entire secondary care process for 
pressure ulcer management took only direct costs de-
rived from spreading the cost over all the activities the 
operators performed [28, 29]. Although the indirect 
costs were not identical for the compared treatments, the 
analysis was performed only on the direct costs.
Based on the methodology of the Health Technology 
Assessment [30], the study developed a qualitative 
model for analyzing what the impact would be on the 
organization using new health technologies (advanced 
dressings), in comparison with the use of old technolo-
gies (simple and saline dressings).
A budget impact analysis was not performed due to the 
fact that, although the sample analyzed represents a real 
sample, it does not represent a complete and total popu-
lation affected by this pathology and treated by health-
care providers within the Italian regions involved in the 
study. A multidimensional approach was used to collect 
additional information to that from the health economic 
evaluation.
The sample population was made up of patients meet-
ing the inclusion criteria enrolled by each provider, after 
giving their written informed consent to participate to 
the study.
Each provider continued to use the type of dressing it 
normally employs in pressure ulcer care. As this was an 
observational study, the research team did not encour-
age or require any change in usual care practices. The 
analysis of the real utilization of advanced and simple 
dressings led to some differences in the two sample con-
sidered.
Observational data were collected on case report forms 
afterwhich a descriptive analysis and an inferential 
analysis of the data was performed using the SPSS 13 
software program. The inferential analysis measured 
the statistical significance of the sample with regards to 
observed costs and lesion characteristics, and whether 
there was a relationship among the variables. Therefore, 
a data analysis per protocol was performed.
The differential organizational impact of the advanced 
dressing use over the 30-day period was then analysed, 
where the weight of the positive or negative organiza-
tional impact of each parameter was determined using 
Delphi methodology [31]: a questionnaire, starting with 
“open questions” was submitted to professionals, each 
of whom had several years of experience within the 
health sector, to determine which variables should be 
assessed. This questionnaire ended with “closed ques-
tions” through successive administrations with a final 
evaluation scale.
The parameters taken into consideration were: the 
number of visits, the time required for each visit, the 
possibility for the health workers involved in the proc-
ess to perform other activities, the personnel required 
for each visit, and the personnel training required which 
included learning time.
Equity data were collected by semi structured inter-
views administered to caregivers, over the 30-day pe-
riod. Three areas of analysis were taken into considera-
tion: accessibility for the family and caregivers, pain, 
and severe adverse events. To analyze this specific di-
mension, a “closed questions” questionnaire with a five 
level evaluation scale was submitted to all families and 
caregivers.
In order to investigate the robustness of the results and 
to explore the impact of hypothetical variations on the 
costs taken into consideration within the study, three dif-
ferent analyses were performed: a sensitivity analysis, a 
bootstrapping analysis and a Monte Carlo simulation.
Simple and multivariate sensitivity analyses were per-
formed varying the following parameters: personnel 
costs, medications and devices used for the advanced 
and simple dressings patients’ costs and transport costs. 
A resampling bootstrapping analysis was performed to 
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create 100 different samples for both the advanced dress-
ings group and the simple dressings one, in order to test 
the variance of the per visit and the 30-day period visits 
cost. In addition, a Monte Carlo simulation was run to 
simulate 100 different scenarios on a five year time pe-
riod, with yearly variations for the costs of personnel, 
medications and devices used for the advanced dressings 
patients and for the simple dressings patients, transport 
costs. The variations were applied on each patient’s cost 
category data in order to better reflect the differences of 
the categories impact on the total cost for each patient. 
The medications and devices costs for the two dressings 
groups were calculated separately to simulate different 
variances of the future costs for advanced dressings and 
of simple ones.
The study was conducted according to the International 
Conference on Harmonisation Good Clinical Practice 
guidelines, each enrolled patient completed an informed 
consent form and authorisation was obtained from the 
Local Health Authorities involved in the study.
Results
The study population consisted of 362 patients, 351 
(97%) of which completed the observation period: 
201 (57.26%) in the advanced dressings group and 
150 (42.74%) in the simple dressings one. 11 subjects 
dropped out of the study, 73% of whom died and 27% 
were hospitalized.
There were no statistically significant differences be-
tween the two groups with regard to gender (P = 0.512), 
age (P = 0.142), comorbidities (P = 0.226), ulcer loca-
tion (P = 0.744) and ulcer depth (P = 0.416) (Tab. I).
Overall, the two groups were similar and comparable for 
the purpose of this study. During the 30-day period, the 
number of visits by a professional health care worker 
to the patient’s home dropped by half in the advanced 
dressings group. This reflects the fact that such dressings 
remain in contact with the skin longer than simple dress-
ings which need to be changed more often.
As expected, the ex-post analysis proved a reduction in 
ulcer size, independently of the type of dressing used, 
demonstration of good nursing practice in terms of se-
lection and dressing chosen for the particular kind of 
ulcer observed.
The mean cost per visit was higher in the advanced 
dressings group (€ 22.31 versus € 16.03). This differ-
ence derives from the higher incurrence of material and 
labor costs for ulcer cleaning and care (> 60% of the cost 
per visit in both treatment groups). Advanced dressings 
purchased from provider (which, in Italy, is the Hospital 
or Local Health Authority) cost more than simple dress-
ings (€ 13.60 versus € 10.78).
However, within the 30-day period, the analysis of the 
monthly mean cost of care imputable to the providers 
favours advanced dressings. The use of advanced dress-
ings requires fewer visits by the health care operators, 
resulting in lower staff costs imputable to the entire 
process which, in turn, offsets the higher purchase cost 
of such dressings (Tab. II).
When applied to ulcer stage, the results of the analysis 
are even clearer. The use of advanced dressings in the 
treatment of stage 2 ulcers (defined as: partial thickness 
loss of dermis presenting as a shallow open ulcer with a 
red pink wound bed, without slough; may also present 
as an intact or open/ruptured serum-filled blister [32]), 
which were more numerous in the simple dressings 
group, produced a saving of 40.17% (€ 199.21 versus 
€ 332.94). The economic advantage of using advanced 
dressings, rather than simple ones, in case of stage 3 ul-
cers (defined as: full thickness tissue loss; subcutaneous 
fat may be visible but bone, tendon or muscle are not 
exposed; slough may be present but does not obscure 
the depth of tissue loss; may include undermining and 
tunnelling [32]) is equal to 20.99% (€ 298.83 versus 
€ 378.24).
Sensitivity analysis to test the robustness of the results 
showed that, within the range of personnel costs, trans-
port expenses, and materials costs, the minimum and 
maximum values led to savings of approximately 27% 
to 29% when advanced dressings were used, rather than 
Tab. I. descriptive analysis of sample data (source: crems and iss reprocessing of study data).
Variables Advanced dressing Simple dressing
sex (p = 0.512) m: 31.3%
f: 68.7%
m: 34.7%
f: 65.3%
age groups (yrs) (p = 0.142) 20-40: 2.4%
41-60: 5.2%
61-80: 33.6%
> 80: 58.8%
20-40: 1.3%
41-60: 6.6%
61-80: 44.4%
> 80: 47.7%
comorbidities (p = 0.226) nervous system 25.6%
psychiatric 24.2%
vascular 10.4%
musculoskeletal 10.0%
other 29.8%
nervous system 33.8%
psychiatric 21.2%
musculoskeletal 15.2%
diabetes 6.6%
other 23.2%
location (p = 0.744) sacral/spinal 57.8%
heel/ankle 27.5%
femor/trochanter 14.7%
sacral/spinal 60.3%
heel/ankle 27.8%
femor/trochanter 11.9%
depth (p = 0.416) 1.17 cm 1.08 cm
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simple ones. These results are similar to those available 
in the literature.
The organizational impact analysis results for advanced 
dressings, are reported in Figure 1 (where the larger the 
impact area referred to each parameter, the higher the 
positive impact on the organization). The use of ad-
vanced dressings has a positive organizational impact 
considering the number of visits within the 30-day peri-
od, the time required for each visit and the possibility for 
health workers to perform other activities. However, it 
has a negative impact when considering personnel learn-
ing time, personnel training required and the number of 
staff required for each visit.
The sensitivity analysis to test the robustness of the re-
sults within the range of staff costs, transport expenses, 
and materials costs, shows variations between +7.49% 
(increasing all the parameters) and -5.32% (decreasing 
medication and device costs, and transport costs) per vis-
it for the advanced dressings group and between +7.61% 
and -5.12% per visit for the simple dressings one.
The same analysis, performed over the 30-day period, 
shows similar results: variations between +7.60% (increas-
ing all the parameters) and -5.53% (decreasing medication 
and device costs, and transport costs) for the advanced 
dressings group and between +7.70% and -5.27% for the 
simple dressings one. The bootstrapping mean values are 
comparable to those found in the literature, with a mini-
mum variance which reaches its highest rate of 0.63%. 
However, considering the maximum and minimum boot-
strapping analysis results, a higher variance can be ob-
served: +9.06% and -8.34% for the simple dressings group 
per visit costs, and +12.73% and -11.40% for the advanced 
dressings one over the 30-day period. The results of the 
Monte Carlo simulation show a mean cost increase within 
Tab. II. mean monthly 30-day period cost of treatment (source: crems and iss reprocessing of study data).
Type of cost Simple dressing Advanced dressing Advanced vs. simple 
dressing Δ
Advanced vs. simple 
dressing Δ
mean monthly cost for health 
worker visits
233.85 € 153.52 € - 80.33 € - 34.35%
mean monthly cost for dressing 
material
58.51 € 72.65 € + 14.14 € + 24.17%
mean monthly transport costs 58.69 € 31.03 € - 27.66 € - 47.13%
mean monthly total cost 351.05 € 257.20 € - 93.85 € - 26.73%
estimated total monthly cost in 
hospital
292.36 € 226.17 € - 66.19 € - 22.64 %
Fig. 1. organizational impact results (source: crems and iss re-
processing of study data).
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a 5 year time period, equal to +6.21% per visit and +6.02% 
considering the 30-day period for the advanced dressings 
group and equal to +5.49% per visit and +5.14% consider-
ing the 30-day period for the simple dressings one. The 
minimum, maximum and mean results of the analysis for 
both scenarios are reported in Figure 2. It is important to 
observe that the use of advanced dressings lead to savings, 
in terms of costs, in all the projections.
The data also showed a greater efficacy of advanced 
dressings. Although a general improvement, as measured 
by the reduction in ulcer size, was noted in both groups 
the ulcers in the advanced dressings group showed a 
wider reduction in terms of lesions’ size (-40,34% ver-
sus -34,34%; P = 0.05).
Considering both cost and effectiveness data, a Cost-
Effectiveness Value (CEV) equal to € 1,022.41 was cal-
culated for simple dressings and equal to € 637.62 for 
advanced ones. The ICER result showed a saving of € 
1,563.57 for each additional effectiveness unit. The use 
of advanced dressings is dominant if compared with the 
use of simple ones, with a lower costs absorption during 
the 30 day period and higher effectiveness (Fig. 3).
Fig. 3. cost-effectiveness analysis of 30-day 
period (source: crems and iss reprocessing of 
study data).
Fig. 2. montecarlo analysis results of 30 days 
treatment’s costs (source: crems and iss re-
processing of study data).
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Conclusions
The results of the study are highly replicable. It may be 
readily applied to community or hospital-based care, in 
addition to being useful for benchmarking between dif-
ferent facilities in Europe, the U.S. or elsewhere.
The decision to consider the sole direct costs, which are 
not related to any regulatory system, increases the gen-
eralizability of the results. Also, the study underlines the 
importance of evaluation, in accordance with the Health 
Technology Assessment methodology, with reference 
to organizational and equity impacts which clearly sup-
ports resource purchasing policies advocating the choice 
of advanced dressings rather than conventional ones, 
and the impact in terms of process efficiency. 
Likewise, the methodology used in this study is easily 
replicable if used in national and international contexts, 
both in the private and public sectors, for hospitals, and 
home care.
For wider populations with different comorbidities and 
wounds stages, the results may vary. However, these 
variations should not be statistically significant, as evi-
denced by the sensitivity analysis performed. It is impor-
tant to note this last aspect for the implications it has on 
the life of the patients and in the context of the treatment 
of wounds.
With the use of advanced dressings, home visits number 
may be reduced by up to 50%. In the 30-day period, vis-
its by the professional health workers dropped by 50%, 
from 22 to 11. This decrease reduces the use of scarce 
resources (personnel) per case treated, thus increasing 
the potential number of home visits and improving the 
delivery of such services.
The data were also analyzed to estimate the cost of in-
patient care. Even when the transport expenses were left 
out of the calculations, the cost for the advanced dress-
ings remained advantageous compared with simple ones 
(cost reduction of 22.64%, see Tab. II).
Despite the negative advanced dressings impact on the 
organization, related to personnel training required, 
learning time, and personnel required for each visit, 
the other parameters have a higher positive organiza-
tional impact compared with simple dressings utiliza-
tion. Moreover, the saving of resources required due to 
less requested access may compensate for the problems 
in the increase of learning time. In the long term, this 
knowledge will certainly have a tangible benefit within 
the organization. If it is true that pressure sores have 
continually presented a problem to the nursing profes-
sion for many years [33], and that many hospitals con-
tinue to evaluate themselves based on the prevalence 
of skin breakdown [34], the correct use of advanced 
dressings may become an organizational solution, thus 
giving a saving in time for skin care and prevention. 
The study assessed a lower resources cost of advanced 
dressings for treatment of pressure ulcers in patients un-
der integrated home care over a 30-day period. Many of 
the health care workers were observed to use an inordi-
nate amount of low-cost materials (e.g., gauze for lesion 
cleaning) although such use was not really necessary. 
One possible explanation of this could be the operators 
limited perception of the economic impact of their ac-
tivities which, from the institution’s viewpoint, in the 
long run generate incremental expenditure. This discrep-
ancy points to the growing need to train health workers 
in the appropriate use of ulcer care materials according 
to wound stage and depth, and the amount of disposables 
in order to give better results and hence, a saving in ex-
penditure.
It is even more relevant in the use of advanced dressings 
where allocation of economic resources for the purchase 
of specialized technical support and devices should be 
seen by the institution as a short-term investment which 
will give long-term savings of up to 50%, widening the 
30-day period used in this study.
For the equity results, assuming the viewpoint of the 
family and caregivers, there is an advantage in the use of 
advanced wound dressings. This is due to the fewer rela-
tive activities during the 30-day period. Accessibility is 
positive for advanced dressings. In addition, concerning 
the perception of the pain, the final results shows an ad-
vantage in using advanced wound dressings rather than 
simple ones. No severe adverse events were detected for 
both wound dressings’ categories and no differences in 
terms of perception were found (Tab. III).
The study highlights the need for a global approach to 
pressure ulcer management as the use of antidecubitus 
devices, correct diet and repositioning cannot be replaced 
by only the usual treatment of the ulcer. Two fundamen-
tal elements necessary for appropriate and complete care 
are: an understanding of pressure ulcer causes and treat-
ment, and a willingness of health workers to train the 
patient’s family and caregiver in wound management. 
The caregiver’s educational training in home care may 
significantly relieve the economic and social burden 
of this avoidable condition. Health workers should be 
ready to train caregivers and improve their skills. With 
this in mind, it is hoped that, in the future, resources will 
be freed for the training of caregivers.
The study also showed the importance of not restricting 
the analysis to institutional decision makers who need 
to operate choices considering economic variables when 
deciding on the type of dressing to be purchased from a 
central supplier and the product unit cost. The assess-
ment of a technological choice impact should focus on 
the process, the analysis of organizational implications, 
and the costs related. A correct health care planning will 
envisage coherent use of economic resources and will 
apply principles of economy and efficiency in the selec-
tion of the best options for the patient and the institution. 
Tab. III. equity impact of 30-day period (source: crems and iss re-
processing of study data).
Criteria Advanced 
dressing
Simple 
dressing
P-value
accessibility for the 
family and care giver
4.6 3.5 0.136
pain 4.5 3.2 0.097
severe adverse event 3.1 3.1
e. foglia et al.
36
At present, efforts to curb ever increasing health care 
expenditure may be guided by operating judicious cost 
saving care choices.
No ethical or equity problems have emerged from the 
study, in terms of the observational study carried out al-
though concern might be expressed with regards to the 
capacity of the Italian Regional Health Care Services to 
cover the patient’s need of advanced dressings: some-
times patients pay for their dressings, and this may be 
considered unethical. Regional Health Care Systems 
should guarantee the availability of these products.
Finally, one limitation of this study to be noted, with 
regards to the centers’ recruitment method, is that as 
participation was voluntary, it might be assumed that 
the operators, and the institutions, gave their patients 
more attention, leading to inevitable improvement in 
institutional performance and reduction in costs re-
corded.
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